viru
result
devast
pandem
explor
compound
could
offer
breakthrough
treatment
need
hour
reposit
cheap
freeli
avail
safe
drug
prioriti
paper
propos
evid
potenti
use
diethylcarbamazin
dec
treatment
dec
inhibitori
effect
arachidon
acid
metabol
prostaglandin
littl
known
antivir
effect
anim
retrovirus
demonstr
antiinflammatori
action
anim
model
lung
inflamm
indic
need
explor
hypothesi
believ
first
time
dec
propos
treat
viru
caus
pandem
approxim
person
affect
countri
death
within
short
period
sever
week
viru
singlestrand
rna
viru
belong
coronavirida
famili
member
caus
mild
infect
howev
epidem
caus
middl
east
respiratori
syndrom
coronaviru
merscov
sever
acut
respiratori
syndrom
coronaviru
sarscov
result
alarm
morbid
mortal
caus
appear
surpass
sever
given
urgenc
outbreak
grow
interest
repurpos
exist
agent
approv
alreadi
develop
novel
drug
improv
clinic
outcom
affect
patient
key
strategi
regard
includ
develop
vaccin
prevent
infect
hottarget
intervent
interferon
therapi
monoclon
antibodi
smallmolecul
drug
despit
extens
research
conduct
antivir
drug
approv
treat
coronaviru
merscov
sarscov
specif
intervent
like
requir
sever
month
even
year
develop
therefor
repurpos
exist
antivir
agent
includ
interferon
chloroquin
antimalari
agent
niclosamid
broad
spectrum
anthelminth
attract
consider
attent
mani
trial
underway
current
paper
review
evid
explor
potenti
diethyl
carbamazin
dec
use
success
therapeut
agent
diseas
affin
angiotensin
convert
enzym
receptor
express
human
respiratori
epithelia
lung
spread
respiratori
tract
lead
fever
cough
subsequ
suscept
seriou
outcom
may
lead
acut
respiratori
distress
syndrom
ard
pathogenesi
sever
diseas
consid
due
cytokin
storm
dysregul
addit
cytopath
effect
viru
local
mainli
lung
due
presenc
high
concentr
viru
bind
receptor
pneumocyt
mani
cytokin
implic
massiv
respons
observ
serious
ill
patient
rapid
activ
cell
lead
prolifer
differenti
cell
secret
proinflammatori
cytokin
respons
consist
high
concentr
sever
ill
patient
requir
intens
care
unit
icu
admiss
higher
concentr
granulocytemacrophag
colonystimul
factor
gcsf
requir
icu
admiss
studi
report
secret
proinflammatori
cytokin
interferon
gamma
granulocytemacrophag
colonystimul
factor
gmcsf
gmcsf
activ
monocyt
releas
lead
format
cytokin
storm
trigger
ard
multiorgan
failur
mof
even
death
furthermor
infect
also
initi
increas
secret
cytokin
suppress
inflamm
phenomenon
seen
sarscov
infect
role
arachidon
acid
relat
prostaglandin
pathway
covid
less
well
known
recent
studi
shown
agerel
chang
pathway
associ
tcell
defect
could
account
increas
suscept
sarscov
infect
elderli
mechan
involv
respiratori
dendrit
cell
rdc
lung
migrat
mediastin
lymph
node
prime
tcell
turn
migrat
lung
mount
immun
respons
agerel
defect
tcell
function
link
decreas
migrat
rdc
increas
level
prostaglandind
age
mice
result
poor
cell
respons
associ
sever
infect
dec
cheap
safe
drug
use
decad
treatment
filariasi
known
antiinflammatori
action
especi
lung
immunemodulatori
effect
poorli
defin
antivir
effect
follow
observ
mechan
postul
consid
role
dec
treatment
dec
wide
rang
immunerel
effect
main
immun
modular
mechan
inhibit
lipoxygenas
lox
cyclooxygenas
cox
enzym
metabol
arachidon
acid
form
prostaglandin
includ
age
lung
associ
high
level
compound
produc
arachidon
acid
cyclooxygenas
enzym
effect
increas
includ
defect
tcell
function
sinc
dec
inhibit
product
theoret
enhanc
cell
respons
respiratori
virus
older
human
dec
therapi
also
shown
enhanc
antibodi
product
mice
immun
tetanu
toxoid
cytokin
respons
anim
immun
lp
facilit
immun
respons
microb
action
dec
lung
injuri
studi
use
model
acut
inflamm
carrageenan
induc
pleurisi
increas
cellular
mild
haemorrhag
congest
apoptot
cell
inflammatori
cell
mononuclear
polymorphonuclear
cell
pulmonari
oedema
emphysema
collagen
fiber
attenu
dec
pretreat
relev
carrageenan
induc
pleural
inflamm
caus
increas
local
activ
pleural
exud
antiinflammatori
effect
use
treatment
follicular
cystiti
bladder
inflammatori
condit
resist
antibiot
nonsteroid
antiinflammatori
agent
addit
evid
support
antivir
activ
dec
rna
virus
mice
inocul
murin
leukem
viru
surviv
significantli
longer
given
dec
present
proven
agent
elimin
lifethreaten
pulmonari
complic
infect
complet
sever
research
group
search
therapi
infect
complic
howev
none
identifi
dec
potenti
therapi
paper
argu
may
worthwhil
consid
use
dec
adjunct
exist
drug
treat
